Frontiers in Pharmacology | Pharmacology of Infectious Diseases

Data Report

Accepted on 23 Jan 2025

Treatment of pediatric central nervous system infection caused by Carbapenem-resistant Klebsiella pneumoniae with Ceftazidime/Avibactam, two cases report and literature review

in Pharmacology of Infectious Diseases

Zhongqiang Liu
Lu Qing
Haiyang Zhang
Xin Pan

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1532608

Brief Research Report

Published on 22 Jan 2025

PBMCs gene expression predicts liver fibrosis regression after successful HCV therapy in HIV/HCV-coinfected patients

in Pharmacology of Infectious Diseases

Ana Virseda-Berdices
Óscar Brochado-Kith
Juan Berenguer
Juan González-García
Leire Pérez-Latorre
Carmen Busca
Cristina Díez
Rafael Micán
Amanda Fernández-Rodríguez
María Ángeles Jiménez-Sousa

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1436198

313 views

Review

Published on 21 Jan 2025

Anti-HSV-1 agents: an update

in Pharmacology of Infectious Diseases

Wenwen Lv
Lei Zhou
Jia Wu
Jishuai Cheng
Yongzhong Duan
Wen Qian

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1451083

318 views

Original Research

Accepted on 20 Jan 2025

Computational and In Vitro Evaluation of Sumac-Derived ©Rutan Compounds Towards Sars-CoV-2 M pro Inhibition

in Pharmacology of Infectious Diseases

Muzaffar Kayumov
Parthiban Marimuthu
Jamoliddin Razzokov
Nurkhodja Mukhamedov
Akmal Asrorov
Nodir S Berdiev
Jamolitdin F Ziyavitdinov
Ansor Yashinov
Yuliya Oshchepkova
Shavkat Salikhov

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1518463

Systematic Review

Published on 20 Jan 2025

Efficacy and safety of tenofovir and entecavir in patients with chronic hepatitis B-related cirrhosis: a systematic review and meta-analysis

in Pharmacology of Infectious Diseases

Lu Cao
Li Li
Lixing Yang
Nan Zhou
Yu Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1507117

320 views

Original Research

Accepted on 14 Jan 2025

Model-guided Development of Pharmacokinetic/Pharmacody-2 namic Cut-offs and Evaluation of Sitafloxacin Dosing Regi-3 mens against Target Pathogens 4

in Pharmacology of Infectious Diseases

Hailan Wu
Yi Li
Xin Li
Yaxin Fan
Beining Guo
Xiaofen Liu
Wanzhen Li
Mengting Chen
Yan Chen
Jing Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1476158

Original Research

Published on 09 Jan 2025

Population pharmacokinetics and dosing optimization of imipenem in Chinese elderly patients

in Pharmacology of Infectious Diseases

Jing Wang
Qiu Fang
Xuemei Luo
Lu Jin
Huaijun Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1524272

236 views

Editorial

Published on 06 Jan 2025

Editorial: Novel pharmacological targets and strategies to treat neglected global diseases (NGDs): an LMIC perspective

in Pharmacology of Infectious Diseases

Kishor M. Wasan
Somia Iqtadar
Celestin Nzanzu Mudogo
Miguel Angel Chávez-Fumagalli

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1527705

584 views

Original Research

Published on 03 Jan 2025

The clinical features and risk factors of coagulopathy associated with cefoperazone/sulbactam: a nomogram prediction model

in Pharmacology of Infectious Diseases

Changjing Xu
Junlong Zhu
Kun Tu
Hui Tang
Xinxin Zhou
Qiuyu Li
Kun Chen
Xuping Yang
Yilan Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1505653

225 views

Original Research

Published on 03 Jan 2025

Efficacy, safety, and therapeutic drug monitoring of polymyxin B sulfate and colistin sulfate in critically ill patients: a real-world retrospective study

in Pharmacology of Infectious Diseases

Yijing Zhang
Chuhui Wang
Jiaojiao Chen
Chuqi Bai
Dan Sun
Yulan Qiu
Mengmeng Teng
Yalin Dong

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1466888

264 views

Review

Published on 19 Dec 2024

Clade Ib: a new emerging threat in the Mpox outbreak

in Pharmacology of Infectious Diseases

Shriyansh Srivastava
Laxmi
Khyati Sharma
Sathvik Belagodu Sridhar
Sirajunisa Talath
Javedh Shareef
Rachana Mehta
Prakisini Satapathy
Ranjit Sah

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1504154

1,044 views

Systematic Review

Published on 19 Dec 2024

Effectiveness and safety of echinocandins combination therapy with the standard of care compared to the standard of care monotherapy for the treatment of invasive aspergillosis infection: a meta-analysis

in Pharmacology of Infectious Diseases

Yazed Saleh Alsowaida
Bader Alshoumr
Shuroug A. Alowais
Khalid Bin Saleh
Alia Alshammari
Kareemah Alshurtan
Haytham A. Wali

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1500529

561 views

Original Research

Published on 18 Dec 2024

Proteomic study of the inhibitory effects of tannic acid on MRSA biofilm

in Pharmacology of Infectious Diseases

Yang Miao
Wang Shuang
Qu Qianwei
Liu Xin
Peng Wei
Yang Hai
Zhou Yonghui
Yu Xinbo

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1413669

539 views

Original Research

Published on 13 Dec 2024

Alhagi maurorum extract in combination with lytic phage cocktails: a promising therapeutic approach against biofilms of multi-drug resistant P. mirabilis

in Pharmacology of Infectious Diseases

Arezoo Mirzaei
Bahram Nasr Esfahani
Mustafa Ghanadian
Jeroen Wagemans
Rob Lavigne
Sharareh Moghim

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1483055

720 views

Original Research

Published on 12 Dec 2024

Which fluoroquinolone is safer when combined with bedaquiline for tuberculosis treatment: evidence from FDA Adverse Event Reporting System database from 2013 to 2024

in Pharmacology of Infectious Diseases

Sheng Wei
Changping He
Xiangping Xie
Anping Zhang
Simin Tang
Sha Li
Yanlang He

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1491921

916 views

Original Research

Published on 12 Dec 2024

Factors influencing vancomycin trough concentration in burn patients: a single center retrospective study

in Pharmacology of Infectious Diseases

Yan Shi
Zongqi Yin
Qin Zhang
Lei Yi
Yi Dou

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1377930

336 views

Navigation group

Articles

Treatment of pediatric central nervous system infection caused by Carbapenem-resistant Klebsiella pneumoniae with Ceftazidime/Avibactam, two cases report and literature review

PBMCs gene expression predicts liver fibrosis regression after successful HCV therapy in HIV/HCV-coinfected patients

Anti-HSV-1 agents: an update

Computational and In Vitro Evaluation of Sumac-Derived ©Rutan Compounds Towards Sars-CoV-2 M pro Inhibition

Efficacy and safety of tenofovir and entecavir in patients with chronic hepatitis B-related cirrhosis: a systematic review and meta-analysis

Model-guided Development of Pharmacokinetic/Pharmacody-2 namic Cut-offs and Evaluation of Sitafloxacin Dosing Regi-3 mens against Target Pathogens 4

Population pharmacokinetics and dosing optimization of imipenem in Chinese elderly patients

Editorial: Novel pharmacological targets and strategies to treat neglected global diseases (NGDs): an LMIC perspective

The clinical features and risk factors of coagulopathy associated with cefoperazone/sulbactam: a nomogram prediction model

Efficacy, safety, and therapeutic drug monitoring of polymyxin B sulfate and colistin sulfate in critically ill patients: a real-world retrospective study

Clade Ib: a new emerging threat in the Mpox outbreak

Effectiveness and safety of echinocandins combination therapy with the standard of care compared to the standard of care monotherapy for the treatment of invasive aspergillosis infection: a meta-analysis

Proteomic study of the inhibitory effects of tannic acid on MRSA biofilm

Alhagi maurorum extract in combination with lytic phage cocktails: a promising therapeutic approach against biofilms of multi-drug resistant P. mirabilis

Which fluoroquinolone is safer when combined with bedaquiline for tuberculosis treatment: evidence from FDA Adverse Event Reporting System database from 2013 to 2024

Factors influencing vancomycin trough concentration in burn patients: a single center retrospective study